Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy.
Parker
Chris
C
Academic Unit of Radiotherapy & Oncology, Institute of Cancer Research and the Royal, Marsden NHS Foundation Trust, Sutton, Surrey, UK. chris.parker@icr.ac.uk
Sydes
Matthew R
MR
Catton
Charles
C
Kynaston
Howard
H
Logue
John
J
Murphy
Claire
C
Morgan
Rachel C
RC
Mellon
Kilian
K
Morash
Chris
C
Parulekar
Wendy
W
Parmar
Mahesh K B
MK
Payne
Heather
H
Savage
Colleen
C
Stansfeld
Jim
J
Clarke
Noel W
NW
D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000379:methods; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000628:therapy*; D016896:Treatment Outcome
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone